Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.
Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...
A jury awarded a Somers man $15 million in compensatory damages Tuesday, siding with claims that years of using Johnson & ...
The article " Johnson & Johnson Stock: Setting the Stage for 2025 Highs " first appeared on MarketBeat.
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
House Speaker Mike Johnson is taking his "American Revival" tour to the swing states with less than three weeks until ...
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...
Republicans won 11 of New York’s 26 House seats two years ago, but their number was reduced by one following the expulsion of ...
Utah Forward candidate Laura Johnson faces off against Republican Rod Hall for the Utah Board of Education District 3 seat.
Paul Johnson is standing down as director of the Institute for Fiscal Studies after more than a decade as one of the most ...
A jury in Bridgeport awarded the money to a man who reportedly developed mesothelioma because of asbestos in Johnson & ...